Peripheral IV Catheter Market

Peripheral IV Catheter Market Outlook (2024 to 2034)

The global peripheral IV catheter market size is estimated to be US$ 1,058.6 million in 2024. The market is projected to register a CAGR of 5.8% and reach US$ 1,865.4 million by 2034.

The rising emphasis on early diagnosis is increasing the use of peripheral IV catheters in the healthcare sector. North America holds a massive share of the peripheral IV catheter market. However, improving healthcare infrastructure and increasing investments in East Asia are projected to provide significant growth potential in the region.

Top Drivers Propelling Growth in the Peripheral IV Catheter Market

• Expanding geriatric population and heightened prevalence of chronic disorders are creating a favorable environment for sales of peripheral IV catheters.
• Increasing rate of hospitalizations and significant consumption of safety-ported short peripheral intravenous catheters are driving the market forward.
• Emerging needs to curtail needle-stick injuries and rising healthcare expenditure are expected to catalyze considerable adoption of peripheral IV catheters.
• Growing awareness of the advantages associated with early diagnosis is increasing the use of peripheral IV catheters to collect blood samples for diagnostic purposes.
• Increasing chronic conditions like diabetes, neurological disorders, infectious disorders, etc., are generating avenues for players to carry out awareness programs about disease treatment, increasing the penetration of peripheral intravenous catheters.
• Investments to develop and produce efficient peripheral IV catheters is projected to stimulate growth in the market, as patient population continues to rise.

Report Attributes	Details
Estimated Market Value (2024E)	US$ 1,058.6 million
Forecasted Market Value (2034F)	US$ 1,865.4 million
Projected Growth Rate (2024 to 2034)	5.8% CAGR
Power Injected PICC Growth Rate (2024 to 2034)	6% CAGR
Hospitals Segment Growth Rate (2024 to 2034)	6.4% CAGR
North America Market Share (2024)	73.1%
East Asia Market Share (2024)	5.8%
Leading Manufacturers Profiled in the Peripheral IV Catheter Industry Report	Becton, Dickinson, and Company B. Braun Melsungen AG Smiths Group plc. Terumo Corporation Venner Medical Vygon Teleflex Incorporated C. R. Bard, Inc. NIPRO Medical Corporation Argon Medical Devices, Inc. Others

Which Trends Dictate Growth of the Peripheral IV Catheter Market?

“Increasing Popularity of Integrated/Closed Catheters”

The adoption of closed catheters, which help insert contrast media during CT scans, is increasing. Rising investments in closed catheters hinge on the fact that they help reduce the risk of healthcare professionals coming into contact with patient’s blood and permit the safe collection of blood samples. The usage of integrated catheters prevents backflow into the cannula tip, and thus, lowers the danger of blockage and the requirement for different insertions.

“Technological Innovation in Peripheral IV Catheters”

Market players are focused on developing advanced monitoring products to increase patient comfort. For this, they are continually financing research and development activities to launch novel medical devices that minimize errors and enhance patient care. Additionally, increasing needlestick injuries are raising the utilization of safer devices, thus raising the demand for peripheral IV catheters.

What is Restraining the Expansion of the Peripheral IV Catheter Market?

“Dearth of Professionals and Lack of Proper Knowledge”

Peripheral IV catheters are commonly used in healthcare settings. However, approximately 35-50% of these catheters do not achieve their dwell time, resulting in difficulties that postpone treatment or even lead to patient discharge. Additionally, the high price of peripheral IV catheters is projected to limit market growth.

Difficulties in the insertion of peripheral IV catheters and a lack of knowledge are two primary factors limiting the market growth. Advanced healthcare practices can minimize such complications and cut down time spent in hospitals.

Region-wise Insights

Which Region Drives the Major Demand for Peripheral IV Catheters?

“Rising Sales of Peripheral IV Catheters in North America”

Attribute	Details
CAGR (2024 to 2034)	4.3%

North America is expected to acquire a market share of 73.1% in 2024. The regional market is estimated to be valued at US$ 773 million in 2024. The market is expected to register a CAGR of 4.3% through 2034. By 2034, the regional market is forecast to achieve a total revenue of US$ 1,178 million.

The market is driven by increasing chronic diseases and expanding population in the region. Advanced healthcare facilities and significant reimbursement coverage in North America are propelling market growth. Moreover, increasing healthcare expenditure and rising investments in technological advancements are contributing to the market.

Which Regional Market is Predicted to Expand Rapidly During the Forecast Period?

“East Asia is Expected to Register Robust Market Growth”

Attribute	Details
CAGR (2024 to 2034)	12%

The East Asia market is anticipated to acquire a 5.8% share in 2024. In 2024, the regional market is estimated to be worth US$ 62 million. By 2034, the market is expected to reach US$ 192 million, recording a CAGR of 12% over the projected period.

The increase in East Asia’s market size is driven by a rising patient pool, supportive policies introduced by regional governments, a robust healthcare industry, and rising local manufacturers selling goods at lower prices. The surge in medical tourism and improvement in healthcare infrastructure are some other factors that are catalyzing market growth.

Country-wise Insights

Which Country in North America Accounts for a Leading Market Share?

“The United States Acquires a Massive Market Share”

Attribute	Details
CAGR (2024 to 2034)	4.2%

The United States is expected to hold a share of 88.6% of the North America market in 2024. The United States peripheral IV catheter market is estimated to gain US$ 685 million in 2024. The market is set to attain US$ 1,029 million, recording a CAGR of 4.2% through 2034.

Increasing pervasiveness of chronic diseases, rising health consciousness, presence of better catheters, and surging surgical procedures are propelling the use of peripheral IV catheters. Additionally, the increasing rate of hospitalizations is raising the market demand. The reimbursement policies for catheters like those provided by the Centers for Medicare and Medicaid Services in the United States are expected to propel market growth.

Which Country in East Asia is Predicted to Register a Substantial Growth Rate?

“China is Projected to Record a CAGR of 13.6% Through 2034”

Attribute	Details
CAGR (2024 to 2034)	13.6%

The China peripheral IV catheter market is expected to account for a value share of 39% of East Asia in 2024. The market is estimated to be valued at US$ 24 million in 2024. By 2034, the market is forecasted to reach US$ 87 million, recording a CAGR of 13.6%.

The demand for peripheral intravenous catheters is rising in China, propelled by factors like increasing chronic diseases, advancing medical technology, rising healthcare spending, and growing medical tourism. The country has a significant population base, which is likely to increase the number of patients suffering from chronic diseases. This is predicted to increase sales prospects for peripheral IV catheters.

Segment-wise Insights

Which End User Drives Higher Demand for Peripheral IV Catheters?

“Demand for Peripheral IV Catheters in Hospitals”

Attribute	Details
Market Share in 2024	72%

The hospital segment is predicted to occupy a 72% share of the peripheral IV catheter market. The segment is estimated to gain US$ 762.1 million in 2024. The segment is projected to expand at a CAGR of 6.4% and generate sales worth US$ 1,411.1 million by 2034.

Increasing hospitalizations, the presence of skilled manpower, and rising incidences of needle stick injuries are anticipated to propel market growth. Further, healthcare providers are motivated to use drug delivery systems like peripheral ICV catheters that enhance patient comfort and reduce risk factors. Thus, improving the segment share of hospitals.

Which Product is Highly Preferred by Market Players?

“Power Injected PICC Gaining Significant Market Traction”

Attribute	Details
Market Share in 2024	83.7%

The power injected PICC segment is predicted to acquire a share of 83.7% in 2024. In 2024, the segment is estimated to gain US$ 886.5 million and register a CAGR of 6% through 2034. By 2034, the segment is forecast to achieve US$ 1,593.8 million.

These catheters utilize pressurized systems to inject fluids or medication into the bloodstream that work much faster than their conventional counterparts. Thus, increasing its adoption as medical professionals seek time-efficient and improved medical equipment. Additionally, due to the closed system of power-injected PICCs, the risk of bacteria entering the catheter diminishes.

Power-injected PICCs are further used to offer an extensive range of medications and fluids, such as chemotherapy drugs, blood products, and antibiotics. Thereby, making it a versatile tool for many medical requirements.

Competitive Landscape

Key players in the peripheral IV catheter market include Becton, Dickinson, and Company, B. Braun Melsungen AG, Smiths Group plc., Terumo Corporation, Venner Medical, Vygon, Teleflex Incorporated, C. R. Bard, Inc., NIPRO Medical Corporation, and Argon Medical Devices, Inc.

The market is extremely competitive and comprises international as well as domestic players. Small and mid-sized firms are concentrating on deeper market penetration by investing in technological advancements. Other organic as well as inorganic strategies employed by players include new product launches, collaborations, partnerships, mergers, and acquisitions.

Recent Developments in the Peripheral IV Catheter Market

• B. Braun Medical Inc. obtained many products from Starboard Medical in September 2022. These products are employed to secure the peripheral catheter of Clik-FIX.
• Shockwave Medical Inc. revealed in March 2022 that Shockwave M5+ peripheral IVL catheter, that gained a CE Mark and FDA certification, is going to be commercially available the world over.
• B. Braun Medical Inc. launched Introcan Safety 2 IV Catheter with single-time blood control in July 2022. This is the latest innovation by B. Braun that increases the safety quotient of IV for clinicians and reduces the risk of blood exposure and needlestick injuries.

Segmentation of Peripheral IV Catheter Market Research

• By Product Type:

  • Power Injected PICC
  • Conventional PICC

• By Design Type:

  • Single Lumen
  • Double Lumen
  • Multiple Lumen

• By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Catheterization Labs

• By Region:

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa